Navigation Links
Global Stroke Survey Launched

AstraZeneca and the Stroke Alliance for Europe (SAFE) today announced the launch of the world's most comprehensive Global Stroke Survey//. The research project, revealed at the European Stroke Conference (ESC) meeting, will assess the true burden of stroke for patients and caregivers, with the first results expected in late 2006.

Arne Hagen, President of the Stroke Alliance for Europe (SAFE) said, ‘We are excited to be partnering with AstraZeneca on this important initiative. The need for education about stroke and stroke prevention is overwhelming -- fifteen million people worldwide suffer a stroke each year. One in three of these people die, a further third are left with varying degrees of disability, and only one third of stroke victims recover without disability (1). Stroke is a life-shattering event, yet very few people can recognise the symptoms or understand the devastating impact stroke can have on patients and families. We look forward to the results of this Global Stroke Survey.’

The Global Stroke Survey will be designed to provide in-depth understanding of the true burden, social consequences, and functional and emotional distress caused by stroke around the world. Variations between countries will also be investigated to build a comparative picture of standards in stroke care across the globe.

Dr. Tomas Odergren, Vice President, Global Product Director, Development at AstraZeneca, commented: ‘Stroke is a medical emergency with potentially devastating consequences if treatment is not sought immediately. Yet poor understanding of the symptoms of stroke often means diagnosis and treatment is delayed. Our hope is that results from this Global Stroke Survey initiative will deepen our understanding of the burden of stroke and contribute to better outcomes for stroke patients in the future.’

The survey will be conducted in France, Germany, Italy, Spain, UK, Sweden, Australia, China, Canada and the USA. Its reach will be extensive; a total of 2,400 patients and 2,400 caregivers will be surveyed following recruitment through medical professionals. A steering committee, consisting of patient organisations like SAFE and leading stroke experts will guide the development of the survey.

AstraZeneca has a firm commitment to stroke research and awareness, and continues to support scientists, physicians, and patients with the aim of improving stroke treatment.

Source: PTI New
'"/>




Related medicine news :

1. SARS-Free Taiwan to Mark End Phase of Global Fight
2. Prevent Global Warming by Becoming A Vegetarian
3. India To March Ahead in The Global HealthCare Competition
4. Global Outbreak Of Bird Flu Warning By Chinese Scientist
5. TWO India Doctors Listed in TIME for Contribution to Global Health
6. Global Hospitals coming to city of Joy
7. John Hopkins CGHH program provides Global Health education
8. Ban on Global fund lifted in Uganda
9. Global Warming Could Cause 5 Million Illnesses: WHO
10. Global Health Bonds to Improve Health Care Facilities for the Underprivileged.
11. Skin Cancer Research To Go Global
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: